Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Mentor silicone submission

This article was originally published in The Gray Sheet

Executive Summary

Mentor has filed a PMA for its Contour Profile silicone gel breast implants, firm announces April 3. The Contour implants are filled with the same Memory Gel for which Mentor received an "approvable" letter for round implants from FDA last summer. Competitor Allergan/Inamed's silicone gel breast implants also sit on a September "approvable" letter. Though neither company will speculate, analysts project FDA approval of both firms' products as early as June 2006 (1"The Gray Sheet" April 3, 2006, p. 6). Furthering its shift to aesthetics, Mentor signed an agreement with Niadyne Inc. on March 20 to distribute Niadyne's NIA 24 skin therapy products...

You may also be interested in...

Allergan Details Revenue Expectations From Newly Acquired Inamed

Allergan expects its recently completed acquisition of Inamed to add $355 mil. to $395 mil. in sales revenue this year

US FDA Not Changing Assessment Goals Because of Coronavirus-Mandated Telework

Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.

Abbott Launches Five-Minute POC Rapid COVID-19 Test

Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts